Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis

Por Heidegger, Isabel, Kern, Johann, Ofer, Philipp, Klocker, Helmut, Massoner, Petra
Publicado em 2014

The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment

Por Dueregger, Andrea, Heidegger, Isabel, Ofer, Philipp, Perktold, Bernhard, Ramoner, Reinhold, Klocker, Helmut, Eder, Iris E.
Publicado em 2014

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo

Por Ofer, Philipp, Heidegger, Isabel, Eder, Iris E., Schöpf, Bernd, Neuwirt, Hannes, Geley, Stephan, Klocker, Helmut, Massoner, Petra
Publicado no Mol Endocrinol (2015)

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide

Por Hoefer, Julia, Akbor, Mohammady, Handle, Florian, Ofer, Philipp, Puhr, Martin, Parson, Walther, Culig, Zoran, Klocker, Helmut, Heidegger, Isabel
Publicado no Oncotarget (2016)

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

Por Hoefer, Julia, Kern, Johann, Ofer, Philipp, Eder, Iris E, Schäfer, Georg, Dietrich, Dimo, Kristiansen, Glen, Geley, Stephan, Rainer, Johannes, Gunsilius, Eberhard, Klocker, Helmut, Culig, Zoran, Puhr, Martin
Publicado em 2014